> Nutra Pharma has inked a deal to buy the shares of ReceptoPharm it doesn't already own. Release
> The Financial Times is reporting that Altana may sell its pharmaceuticals division to financial investors. Report
> Shares of the U.K.'s BTG dropped after it announced it would proceed with a Phase II study of an experimental therapy for varicose veins without a hoped-for development partner. Report
> Medarex announced that the FDA has approved a clinical trial of MDX-010 for suppressing cancerous tumors. Report
> ISTA Pharma has licensed the North American rights to two drug candidates from Senju Pharma. Report
> Cytogen says early results for a clinical trial of its experimental therapy for bone cancer, Quadramet, demonstrated some results for patients. Report
> Three executives from the Italian drug company Recordati were arrested on charges they bribed doctors to prescribe their therapies. Report
> Beijing-based Sinovac has reported positive results from an early study of an avian flu vaccine. Report
> NovaCardia presented positive results from two Phase II trials of KW-3902, a proprietary adenosine A1 receptor antagonist in development for the treatment of congestive heart failure at the Heart Failure 2006 Congress taking place in Helsinki, Finland. Release
And Finally... The mixing of animal and human cells is growing more exotic. Article (WSJ sub. req.)